Australian Drug Industry Toughens Code On Payments To Doctors
This article was originally published in SRA
Executive Summary
Drug industry group Medicines Australia has, as of the beginning of this month, made it mandatory for its member companies operating in Australia to collect information about any payments they make to healthcare professionals for consulting services and any financial support they provide for educational purposes, including airfares, accommodation and conference registration fees.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.